(1)
Potential Role of Interleukin 28B-Gene Polymorphism and Natural Immune Enhancer Treatment Response in Chronic HCV Patients. J Biochem Microbiol Biotechnol 2015, 3 (1), 15-20. https://doi.org/10.54987/jobimb.v3i1.230.